Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer

被引：26

作者：

Sternberg, C. N. ^{[1
]}

机构：

[1] San Camillo Forlanini Hosp, Dept Med Oncol, Rome, Italy

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn473

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：91 / 95

页数：5

共 44 条

[1] A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: A TAX327 study analysis [J].

Armstrong, Andrew J. ;

Garrett-Mayer, Elizabeth S. ;

Yang, Yi-Chun Ou ;

de Wit, Ronald ;

Tannock, Ian F. ;

Eisenberger, Mario .

CLINICAL CANCER RESEARCH, 2007, 13 (21) :6396-6403

[2]

ATTARD G, 2007, AACR ANN M, V48

[3] ASCENT: The androgen-independent prostate cancer study of calcitriol enhancing taxotere [J].

Beer, TM .

BJU INTERNATIONAL, 2005, 96 (04) :508-513

[4] Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators [J].

Beer, Tomasz M. ;

Ryan, Christopher W. ;

Venner, Peter M. ;

Petrylak, Daniel P. ;

Chatta, Gurkamal S. ;

Ruether, J. Dean ;

Redfern, Charles H. ;

Fehrenbacher, Louis ;

Saleh, Mansoor N. ;

Waterhouse, David M. ;

Carducci, Michael A. ;

Vicario, Daniel ;

Dreicer, Robert ;

Higano, Celestia S. ;

Ahmann, Frederick R. ;

Chi, Kim N. ;

Henner, W. David ;

Arroyo, Alan ;

Clow, Fong W. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) :669-674

[5] Tumorigenesis and the angiogenic switch [J].

Bergers, G ;

Benjamin, LE .

NATURE REVIEWS CANCER, 2003, 3 (06) :401-410

[6] Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study [J].

Berthold, Dominik R. ;

Pond, Gregory R. ;

Roessner, Martin ;

de Wit, Ronald ;

Eisenberger, Mario ;

Tannock, Ian F. .

CLINICAL CANCER RESEARCH, 2008, 14 (09) :2763-2767

[7] Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study [J].

Berthold, Dominik R. ;

Pond, Gregory R. ;

Soban, Freidele ;

de Wit, Ronald ;

Eisenberger, Mario ;

Tannock, Ian F. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) :242-245

[8] Management of advanced prostate cancer after first-line chemotherapy [J].

Berthold, DR ;

Sternberg, CN ;

Tannock, IF .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) :8247-8252

[9]

Bok RA, 2001, CANCER RES, V61, P2533

[10]

Borre M, 2000, CLIN CANCER RES, V6, P1882

← 1 2 3 4 5 →